Mid- and long-term results of open repair for chronic type B aortic dissection in endovascular era

Akitoshi Takazawa1, Toshihisa Asakura2, Osamu Kinoshita2

  • 1Department of Cardiovascular Surgery, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka City, Saitama, Japan. a.takazawa.cvs@gmail.com.

Heart and Vessels
|March 27, 2024
PubMed

Insights

Open surgical repair (OSR) offers better mid- and long-term outcomes for chronic type B aortic dissection (CTBAD) compared to thoracic endovascular repair (TEVAR). Despite OSR

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Vascular Surgery

Background:

  • Medical management is standard for chronic type B aortic dissection (CTBAD).
  • The comparative efficacy of open surgical repair (OSR) and thoracic endovascular repair (TEVAR) for CTBAD remains debated.
  • This study evaluates mid- and long-term outcomes of OSR versus TEVAR in CTBAD patients.

Purpose of the Study:

  • To compare the mid- and long-term clinical outcomes of OSR via left thoracotomy with TEVAR for CTBAD.
  • To assess survival rates, aorta-related deaths, and re-intervention rates between the two surgical approaches.

Main Methods:

  • Retrospective review of 85 consecutive CTBAD patients undergoing OSR (n=33) or TEVAR (n=52) from April 2007 to May 2021.
  • Analysis of preoperative and postoperative computed tomography (CT) scans for maximum aortic and false lumen diameters.
  • Mean follow-up duration of 5.8 years, evaluating complications, survival, aorta-related deaths, and re-interventions.

Main Results:

  • No operative mortality; similar rates of stroke, paraplegia, and respiratory failure between groups.
  • Significant differences in preoperative factors: OSR patients had longer intervals from onset to operation and larger aortic diameters.
  • No significant differences in mid- to long-term survival, aorta-related deaths, or re-intervention rates overall; however, TEVAR group experienced severe postoperative complications (e.g., fistula, type A dissection), and outcomes reversed after seven years, favoring OSR.

Conclusions:

  • While TEVAR is less invasive, its mid- and long-term re-intervention freedom was unsatisfactory, with fatal complications observed.
  • OSR, despite being invasive, demonstrated safer perioperative outcomes and more favorable mid- and long-term results compared to TEVAR.
  • OSR may be a more suitable option for achieving better long-term outcomes in select CTBAD patients.